Halma (HLMA)

Sector:

Electronic and Electrical Equipment

Index:

FTSE 100

2,219.00p
   
  • Change Today:
      41.00p
  • 52 Week High: 2,498.00
  • 52 Week Low: 1,810.50
  • Currency: UK Pounds
  • Shares Issued: 379.65m
  • Volume: 606,327
  • Market Cap: £8,424m
  • RiskGrade: 112

Halma buys Rovers Medical for €85m

By Frank Prenesti

Date: Monday 04 Mar 2024

LONDON (ShareCast) - (Sharecast News) - Health tech company Halma on Monday said it had bought Netherlands-based Rovers Medical Devices for €85m (£73m).
Rovers designs and makes sample collection devices used in the prevention and diagnostics of cervical cancer, Halma said in a statement. An extra payment of €6m is payable in cash, based on Rovers' performance in the period to March 31, 2025.

Unaudited revenue for the 12 months to 31 December 2023 was €12.0m, with return on sales more than double Halma's target range of 18-22%. Rovers will be a standalone company within Halma's Healthcare sector, led by its current management team, Halma added.

Reporting by Frank Prenesti for Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Halma Market Data

Currency UK Pounds
Share Price 2,219.00p
Change Today 41.00p
% Change 1.88 %
52 Week High 2,498.00
52 Week Low 1,810.50
Volume 606,327
Shares Issued 379.65m
Market Cap £8,424m
RiskGrade 112

Halma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
89.44% below the market average89.44% below the market average89.44% below the market average89.44% below the market average89.44% below the market average
94.12% below the sector average94.12% below the sector average94.12% below the sector average94.12% below the sector average94.12% below the sector average
Price Trend
30.31% above the market average30.31% above the market average30.31% above the market average30.31% above the market average30.31% above the market average
43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average
Income
71.46% below the market average71.46% below the market average71.46% below the market average71.46% below the market average71.46% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Growth
4.68% below the market average4.68% below the market average4.68% below the market average4.68% below the market average4.68% below the market average
29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 9
Sell 1
Strong Sell 2
Total 15
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Halma Dividends

  Latest Previous
  Interim Final
Ex-Div 21-Dec-23 13-Jul-23
Paid 02-Feb-24 18-Aug-23
Amount 8.41p 12.34p

Trades for 26-Apr-2024

Time Volume / Share Price
16:35 339,991 @ 2,219.00p
16:35 1,892 @ 2,219.00p
16:35 146 @ 2,219.00p
16:35 3,044 @ 2,219.00p
16:35 309 @ 2,219.00p

Halma Key Personnel

CEO Marc Ronchetti
Chair Dame Louise Makin
CFO Steve Gunning

Top of Page